If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »This product is covered by the Abpromise guarantee. Our scientific support team are available to answer any questions or queries - fill out an inquiry form for ab5716 for help.
Alternatively, you can search the previous enquiries about this product to see if your query has already been answered.
|
|||||||||
|
|||||||||
Hello, I would like to know if your DC-SIGN antibody will block DC-SIGN's binding pocket, in otherword, can the antibody bind DC-SIGN while it is simultaneously binding a sugar? Thank you
|
|||||||||
ANSWER: |
Thank you for your enquiry. This antibody was raised against residues 277 to 293 of human DC-SIGN. This region is part of the C-type Lectin Domain. Unfortunately, since this antibody is generated against a linear peptide from the protein, we do not know how the antibodies will bind to the protein in the native conformation and affect the binding sites. We apologise for the inconvenience, |
||||||||
|
|||||||||
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
ab5716 at 2 µg /ml staining approximately 44kDa of human CD209 in Human placenta tissue lysate by Western blot (ECL). Lane 1 absence of blocking peptide and Lane 2 presence of blocking peptide.
Immunohistochemistry of DC-SIGN in human small intestine tissue with DC-SIGN antibody at 10 µg/ml.
0
Call 01223 696 000 or contact us